Clinical trial Recruiting at 1 site Interventional Ages 18 to 64

Education program to help adults with asthma adapt using the Roy Adaptation Model

Official title: The Effect of Education Given to Asthmatic Individuals According to Roy Adaptation Model on Psychosocial Adjustment and Quality of Life

Run by Nigde Omer Halisdemir University · NCT06766136 · Data updated 2026-11-12

This program will test whether an education program based on the Roy Adaptation Model helps adults with asthma improve their psychosocial adjustment and quality of life.

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment36 (estimated)
SponsorNigde Omer Halisdemir University
Academic / other
Locations1 site (Niğde, Center)
StatusRecruiting
StartedDecember 20, 2024
Main results expectedMay 1, 2025
Study endsOctober 1, 2025
Registry record updatedJune 15, 2025
Trial IDNCT06766136 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–64 diagnosed with asthma for at least six months, living in the city center, with ACT scores indicating partial control (20–24) or uncontrolled asthma (≤19), and able to communicate in Turkish are ideal candidates.

Probably not a fit

Patients with additional chronic diseases, neuropsychiatric diagnoses, sensory or language barriers, or those with well-controlled asthma are unlikely to gain benefit from this specific program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial enrolls adults aged 18–64 with asthma who have partial control (ACT 20–24) or uncontrolled asthma (ACT ≤19) to receive a structured education program based on the Roy Adaptation Model. Participants are randomized to the education intervention or usual care, with regular, planned sessions designed to improve self-management behaviors and adaptation to living with asthma. Primary outcomes are psychosocial adjustment and disease-specific quality of life measured with validated tools, with follow-up assessments to track changes over time. The trial is conducted at Niğde Ömer Halisdemir University and excludes patients with other chronic diseases or communication barriers.

Why it matters

Potential benefit: If successful, the program could help people with asthma manage their condition better, improve their psychosocial adjustment, and increase quality of life.

How similar studies have gone: Previous asthma education programs have produced modest improvements in self-management and quality of life, but the Roy Adaptation Model–based approach has been less frequently tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being in the age range of 18-64
* Diagnosed with asthma for at least 6 months
* To live in the city center
* Asthma control test (ACT) score 24-20 (partial control) or ≤19 (uncontrolled)
* Patients who voluntarily agreed to participate in the study

Exclusion Criteria:

* Has a secondary chronic disease other than asthma
* Diagnosed with neuropsychiatric illness
* Individuals with inability to understand or speak Turkish and sensory problems that prevent communication

Where it's running

  • Nigde Omer Halisdemir University
    Niğde, Center, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Dondu Erdogan Inan, MSc — Nigde Omer Halisdemir University
  • Study coordinator: Dondu Erdogan Inan, MSc
  • Email: derdoganinan@ohu.edu.tr
  • Phone: +903882112815

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.